|
HS Code |
497899 |
| Product Name | 2-Isopropoxypyridine-5-boronic acid |
| Cas Number | 1111734-87-2 |
| Molecular Formula | C8H12BNO3 |
| Molecular Weight | 180.00 |
| Appearance | White to off-white solid |
| Purity | Typically ≥97% |
| Solubility | Soluble in DMSO, DMF, moderately in water |
| Storage Conditions | Store at 2-8°C, protected from moisture |
| Smiles | CC(C)OC1=NC=C(C=C1)B(OH)2 |
| Inchi | InChI=1S/C8H12BNO3/c1-6(2)13-8-5-7(9(11)12)3-4-10-8/h3-6,11-12H,1-2H3 |
| Synonyms | 5-Borono-2-(propan-2-yloxy)pyridine |
As an accredited 2-Isopropoxypyridine-5-boronic acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 1-gram quantity of 2-Isopropoxypyridine-5-boronic acid is supplied in a sealed amber glass vial with tamper-evident cap. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 2-Isopropoxypyridine-5-boronic acid: Securely packed in drums, ensuring moisture protection, UN-compliant, with clearly labeled dangerous goods documentation. |
| Shipping | 2-Isopropoxypyridine-5-boronic acid is shipped in tightly sealed containers, protected from moisture and direct sunlight. All packaging complies with international chemical transport regulations. It is labeled as a research chemical and may require temperature control during transit, depending on manufacturer recommendations. Standard documentation accompanies the shipment for safe and legal handling. |
| Storage | 2-Isopropoxypyridine-5-boronic acid should be stored in a tightly sealed container under an inert atmosphere, such as nitrogen or argon, to prevent moisture uptake and degradation. Store in a cool, dry place away from direct sunlight, heat sources, and incompatible substances such as strong oxidizers. Properly label the container and keep it in a well-ventilated chemical storage cabinet. |
| Shelf Life | 2-Isopropoxypyridine-5-boronic acid should be stored cool and dry, with a typical shelf life of 2 years unopened. |
|
Purity 98%: 2-Isopropoxypyridine-5-boronic acid with purity 98% is used in Suzuki-Miyaura cross-coupling reactions, where it ensures high yield and selectivity in biaryl synthesis. Molecular weight 180.01 g/mol: 2-Isopropoxypyridine-5-boronic acid at molecular weight 180.01 g/mol is used in pharmaceutical intermediate development, where precise dosing and reproducibility are achieved. Melting point 110°C: 2-Isopropoxypyridine-5-boronic acid with melting point 110°C is utilized in automated solid-phase synthesis protocols, where consistent product quality and processing reliability are maintained. Particle size <100 μm: 2-Isopropoxypyridine-5-boronic acid with particle size less than 100 μm is applied in high-throughput screening, where rapid dissolution and uniform reactivity are provided. Stability temperature up to 80°C: 2-Isopropoxypyridine-5-boronic acid stable up to 80°C is used in heated batch reactions, where compound integrity and minimized decomposition are ensured. |
Competitive 2-Isopropoxypyridine-5-boronic acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In over two decades making heterocyclic boronic acids, the difference between lab-scale trials and full-batch industrial runs has taught us to look for real, hands-on results. Among our lineup, 2-Isopropoxypyridine-5-boronic acid stands up as a practical, well-balanced tool for research and scale-up in pharmaceutical intermediates and modern organic synthesis. As a manufacturer, experience shows that true value lies in how a compound fits users’ process needs—right down to stability, reactivity, and workflow compatibility. Not every boronic acid works out where Suzuki-Miyaura coupling reactions are involved, especially once process constraints, sample loss, and purity come into play. That’s where thoughtful design and consistent quality become more than just selling points.
Years in the field reveal that pyridine-based boronic acids provide remarkable versatility in cross-coupling reactions, especially for building blocks that bring both aromatic nitrogen and differentiated substituents into play. 2-Isopropoxypyridine-5-boronic acid, in particular, brings together a protected pyridine core and a selectively-placed isopropoxy group. That structure bridges the needs of chemists working with pyridines and those who require boronic acids with more nuanced steric and electronic effects.
The isopropoxy substituent does more than just set the molecule apart structurally. It delivers improved handling and, in some settings, offers a level of steric shielding that reduces undesired side reactions. Through trial and error in our pilot plant, our staff have seen that this compound’s melting behavior and reluctance to ‘cake’ under common ambient conditions reduces operational headaches associated with some other boronic acids, which tend to clump or degrade even after short-term storage. A reliable solid-crystalline product that doesn’t frustrate users’ hopes for stability or ease-of-weighing stands out right away in day-to-day use.
From our synthesis facility, we run quality checks to maintain batch purity, minimize residual inorganic byproducts, and verify NMR signatures after production. Not every lot from every producer will perform the same way on the bench; that is where hands-on oversight, thoughtfully maintained reaction conditions, and real-world storage data make a difference. Issues like hydrolysis and oxidation can be tamed with careful process controls, which reflects in the shelf life and reactivity profile reported back by our regular clients.
Picture a facility with climate-monitored synthesis rooms, and teams running reactor feeds under repeated, validated conditions. Even small changes in temperature control, quenching technique, or solvent handling leave their mark on boronic acid chemistry. In the case of 2-Isopropoxypyridine-5-boronic acid, years of production trials have led us to optimize coupling and borylation steps for both batch and continuous-flow setups. One critical finding: certain solvents and catalysts do a better job at preserving both the pyridine ring and the sensitive boronate group. The isopropoxy group, sometimes overlooked in design, really earned its keep as we discovered it protected the core from side reactions during the borylation sequence, which translates to higher isolated yields and less waste.
This experience translates directly to the hands of our customers; with each improved run, we’ve cut down both on purification steps and on the need for repeated drying, crystallization, or filtration. Direct feedback from users, particularly in API intermediate work, confirms that higher NMR-purity product with minimal clumping translates to lower time spent troubleshooting at their site. As manufacturers, we keep a close eye on those points because fewer customer complaints mean our own resources stay focused on optimization and innovation rather than firefighting.
Spec sheets rarely tell the full story. Many labs set out to use boronic acids in complex coupling steps, only to be confounded by subtle sources of loss: moisture sensitivity, variable melting point behavior, or unseen particulate contamination. In our view, small improvements—a little extra melting point consistency, better flow during transfer, or less static—directly save users hours per month. With 2-Isopropoxypyridine-5-boronic acid, our routine spec runs prioritize limits on residual solvents and water because experience shows that even ppm levels of certain contaminants can scuttle sensitive palladium-catalyzed couplings. For that reason, all our outgoing batches get checked for controlled moisture content and are shipped under sealed conditions, as both stability and coupling efficiency trace back to careful packaging right at the source.
Running kilo-scale reactions using pyridine boronic acids exposes a company to the full spectrum of real-world chemical headaches. Reactivity often drops off sharply if the reagent is not maintained or produced with technical vigilance. Over the years, seeing clients tackle new drug candidates and specialized heterocycle libraries, we’ve adjusted our synthesis, drying, and storage methods to keep byproducts from creeping above detection limits. For example, where many producers cut corners on extended drying, we learned that careful vacuum-drying, right after crystallization and before every shipment, helps safeguard both analytical profiles and downstream cross-coupling reproducibility.
There’s more to the equation than producing a dry, white solid. Research chemists ask us about hidden impurities—things like isopropanol residues or pyridine ring oxidized side products—and answerability matters here. Having built our own analytics in-house, from NMR to HPLC/GC, we stay swift in troubleshooting and documentation, giving users real measures and batch data rather than generic, third-party certificates. Over time, this has built trust with R&D partners who need not just a product, but full-length support for their complex synthetic problems.
In our catalog, the family of pyridine boronic acids displays lots of subtle variations—a methyl group here, a methoxy group there—which influence more than just structure diagrams. 2-Isopropoxypyridine-5-boronic acid crosses a sweet spot: its isopropoxy moiety increases both steric and electronic effects that chemists leverage to modulate reactivity, yet the molecule avoids the high moisture sensitivity of some alkoxy- or amino-boronic acid variants. Practical lab feedback confirms that this pays off with higher-conversion cross-couplings under both oxygen-sensitive and mildly moist conditions, reducing the likelihood of dropped yields due to side hydrolysis or unexpectedly rapid decomposition.
Compared with simple pyridine-5-boronic acid, the isopropoxy version resists aeration and breakdown a little better—a fact proven out in week-long storage studies and daily usage. In process optimization, such differences add up: chemists can plan runs without as much rush after opening containers. Contrasted with more heavily substituted boronic acids, this compound keeps a balance between necessary reactivity and manageable handling. Some other boronic acids tend to offer higher reactivity at the expense of shelf stability; based on side-by-side production notes, we have seen fewer complaints from customers using the isopropoxypyridine derivative for repeated benchwork.
As a manufacturing group with strict environmental compliance, solving waste issues forms a daily challenge. Boronic acid wastes—residual solids, byproducts, spent catalysts—pose problems both upstream and downstream. Back when we scaled production, minor modifications to the purification and isolation process for 2-Isopropoxypyridine-5-boronic acid cut our solid waste output by nearly fifteen percent. These improvements came from batch filtration technique upgrades and careful attention to solvent selection, not from offloading or externalizing the issue. In real time, this shrinks both our operational cost and our customers' hazardous disposal burden.
For users keen to reduce bottlenecks, direct input from larger scale formulators and process chemists informed tweaks to the particle size and flow attributes of our product shipments. Any change in these physical parameters required us to rethink our plan for drying and packaging, as even a subtle grain size shift can impact everything from automated dispensing to bench-top weighing. Over the years, close collaboration with research partners, not just passing spec sheets down the line, has proven the most effective path to finding real solutions—and ultimately, better yields and output reliability for the end users’ own processes.
Custom synthesis rarely moves in straight lines. For pharmaceutical researchers, the ability to plug in a pyridine boronic acid with well-defined properties into late-stage functionalization or fragment-coupling steps makes or breaks projects. 2-Isopropoxypyridine-5-boronic acid has become a staple for teams developing kinase inhibitors, CNS agents, and next-generation crop protection leads, because its balanced substitution pattern integrates smoothly into aromatic substitution and cross-coupling steps. Drug-discovery feedback looped straight into our process habits: each batch we send out often leads to new insights, as R&D chemists frequently return with yield reports, impurity logs, or requests for tweaks in morphology or packing.
Having a direct line to development groups, rather than relying on intermediaries or bulk traders, encourages honest dialogue and technical support, freeing us from the disconnection that can cause research to stall. Whether a client requests a single multi-kg run or repeated kilo-lots on seasonal demand, this communication helps us forecast demand, tailor storage conditions, and guarantee on-time delivery. Timing remains everything in R&D, particularly in projects with narrow funding or tightly controlled development windows. Each batch shipped builds that trust—delivering a product that does what our clients expect, with the data to back it up.
Recent years have shown how fragile global chemical supply networks can be. Across the specialty boronic acid sector, disruptions and shortages spike unpredictably. We buffer production by maintaining a rolling inventory of key precursors, and by investing in local supplier networks for starting materials. This planning has shielded our clients from supply volatility that often hits especially hard when niche intermediates run short. Our in-house synthesis for 2-Isopropoxypyridine-5-boronic acid stands apart because we never source from anonymous third-party aggregators—our feedstocks move straight from tested, verified suppliers to our own reactors.
Late deliveries and variable batch quality cost both the research organization and the manufacturer. After several incidents in the larger market where generic boronic acid lots failed in key reactions—sometimes due to unseen degradation or contamination—our team doubled down on in-process QC and incremental batch validation. Instead of pushing for maximum throughput at the expense of repeatable results, our strategy balances consistent output quality with steady volume, keeping the channel open for both routine repeat orders and one-off custom requests. Researchers remember the source of a batch that performs as expected, and in our experience, that reliability builds reputation faster than marketing language ever could.
Operating in today’s regulatory landscape, real consequences flow from traceability—or the lack of it. Clients need proof that materials follow strict protocols, free from cross-contamination, and that each batch can be tracked from raw material procurement down to delivered package. Our internal traceability links every lot of 2-Isopropoxypyridine-5-boronic acid to individual synthesis runs, analytical records, and shipment logs. This level of detail grew out of audit after audit, as well as lessons learned facing new compliance regimes in both drug and agrochemical markets. Our experts maintain the documentation not just for regulatory bodies, but as a tool for rapid troubleshooting and honest conversations with partners.
Responsible manufacturing goes hand in hand with safer workplaces and ecological stewardship. On the shop floor and in the plant, operators review protocols for safe handling, dosing accuracy, and waste reduction at every batch meeting. We train every new employee to spot early warning signs of process drift, so production stays within strict limits and repeat problems never get passed along to our customers. This investment shows up in the consistent purity, color, and reactivity of our finished product.
Real-world challenges rarely match textbook predictions. For example, some clients encountered sticking and incomplete dissolution using boronic acids from other suppliers, leading us to refine drying cycles and to perform regular particle morphology checks before every major shipment. On one occasion, a customer’s synthesis line suffered from catalyst poisoning traced to a minor batch contaminant—an event that led us to invest in higher-resolution analytical checks, catching similar problems before product ever leaves our plant again.
Solutions to field problems often spring from listening to technical teams on the user side. In one project, a medicinal chemistry team reported secondary crystallization issues in downstream steps. We ran side-by-side test batches using varying levels of controlled hydration and fine-tuned our own drying and storage process, cutting their downstream filtration time almost in half. Such learning by doing doesn’t make it into traditional spec sheets, but the benefits end up reflected in real user feedback—faster throughput, less process waste, and higher reproducibility.
Years of hands-on work and problem-solving have shown that 2-Isopropoxypyridine-5-boronic acid’s utility lies in more than simply filling an order. The compound provides consistent, robust performance in cross-coupling, supports rational design in heterocyclic chemistry, and meets standards for handling and compliance that save users both time and resources. From the factory manager to the research chemist, each step of the synthesis, packaging, and delivery process factors into a stronger, more predictable workflow. In practice, improvements made by chemists and operators on the ground feed directly into ongoing refinements, closing the loop between finished product and future innovation.
Our commitment stays rooted in practical reality: meet the exacting needs of our users with reliability, safety, and performance that endures trial after trial, year after year. The continuing story of 2-Isopropoxypyridine-5-boronic acid plays out every day in research labs, synthesis vessels, and production lines around the world—and each successful application reflects the care, skill, and experience that only a direct manufacturer can bring to the table.